HIV control: Is getting there the same as staying there?

Existing Reviews

Please note, new claims can take a short while to show up.

No claims yet.

Annotation Summary

Term Occurence Count Dictionary
AIDS 2 infectiousdiseases
abacavir 1 infectiousdiseasesdrugs
hepatitis C 1 infectiousdiseases
infectious disease 1 infectiousdiseases

Graph of close proximity drug and disease terms (within 200 characters).

Note: If this graph is empty, then there are no terms that meet the proximity constraint.


Having read the paper, please pick a pair of statements from the paper to indicate that a drug and disease are related.

Select Drug Character Offset Drug Term Instance
abacavir 28244 a cost, however, because this allele is associated with hypersensitivity reactions, most notably to abacavir [[110]]. Similarly, HLA-B*27:02 and HLA-B*27:05 are protective against HIV but also associated with
Select Disease Character Offset Disease Term Instance
AIDS 22367 [[76]–[81]].Although women may control HIV more often than men and have lower viral load set points, women progress to AIDS at a more rapid rate for any given viral load than men [[82]]. High levels of immune activation for
AIDS 23232 chronic phase in females is associated with higher risk of losing virus control and progressing to AIDS . The consistent observation that women have much higher rates of a number of autoimmune diseases (e.g.,
hepatitis C 21545 more likely than men to be elite controllers [[65]]. Females are also more likely than males to clear hepatitis C virus (HCV) in the absence of treatment [[72]]. Mechanistically, it has been argued that plasmacytoid
infectious disease 33780 targeted therapeutically [[127], [128]]. The fact that blocking this pathway also increased the risk for infectious disease complications highlights the “double-edged sword” problem that we argue here will always need to

You must be authorized to submit a review.